Final Program [International Conference on AIDS (14th: 2002: Barcelona, Spain)]

Poster Exhibitions

Thursday July ii

Po te Ex iiin Thrsa Jul, -7IF -I
ThPeA7144 High levels of cAMP contribute to the T cell
dysfunction in H IV: protein kinase A type I
antagonist increases HIV and CMV specific
immune responses in T cells from H IV patients
EM Aandahl', W ] Moretto', J Harris', D Schmidt',
J M McCune', PA Haslett', K Tasken2, D F Nixon'
('United States; 2Norway)
ThPeA7145 Influence of HIV viremia and T-lymphopenia on
the regulation of plasma interleukin-7 (IL-7)
levels M R Boulassel, J P Routy, G H R Smith,
M Klein, J MacLeod, N Gilmore, S Bruce,
PR Sekaly, R G Lalonde (Canada)
ThPeA7146 Longitudinal evaluation of plasma interleukin-7
(IL-7) levels in advanced HIV-patients treated
with Kaletra/Saquinavir containing regimen
M R Boulassel, J P Routy, N Klein, N Gilmore,
N LeBlanc, J MacLeod, S Bruce, R G Lalonde,
G H R Smith (Canada)
ThPeA7147 Recovery of immune responses to Mycobacterium
avium after HAART in HIV-infected patients
A P Kourtis, S Lukashok, C I lbegbu
(United States)
ThPeA7148 Quantitative analysis of CD38 expression on CD8
cells in HIV-1 infected patients
J M Benito, M Lopez, S Lozano, P Martinez,
J Gonzalez-Lahoz, V Soriano (Spain)
ThPeA7149 Varied and unusual autoimmune thyroid disease
phenotypes in a cohort of immune reconstituted
HIV patients
FChen SLDay, G Sethi, C Y W Tong, H Simpson,
R A Metcalfe, J Welch, S G Edwards, D A Lewis,
G Scullard, C ] Lacey, J N Weber, A P Weetman,
S Robinson, M S Kapembwa, A de Ruiter
(United Kingdom)
ThPeA715o The impact of HAART on HIV-specific CD8+ cell
responses in subjects with moderately advanced
HIV infection
E Connick, R Schlichtemeier, A Mian, R Kim,
R Bosch, M Lederman, A Landay (United States)
ThPeA7151 Immunological and virological correlates of
intermittent interleukin-2 (IL-2) therapy
S Ghezzi, F Neri, C Fortis, F Pacciarini, G Vallanti,
L Soldini, S Nozza, A Lazzarin, G Tambussi, G Poli
(Italy)
ThPeA7152 Longitudinal follow-up of patients with
discordant responses to pi-based HAART
S Sufka, G Ferrari, G Tomaras, T Wrin, S Fiscus,
V Gryszowka, V Teaberry, N Hellmann,
K Weinhold, C Hicks (United States)
ThPeA7153 IL-7 production by bone marrow-derived stromal
cells in HIV-1 infected patients during HAART
A Isgrb, I Mezzaroma, A A Aiuti, E Pinter,
A M Mazzone, F Lebba, FAiuti (Italy)
Thursday ThPeA7154 IL-15 enhances IFN-y production by CD4 and CD8
T-cells from HIV-infected patients
G d'Ettorre, G Forcina, M Carnevalini, G Ceccarelli,
N F Di Campli, CM Mastroianni, V Vullo (Italy)
ThPeA7155 Immunological reconstitution during HAART in
HIV-1 vertically infected infants
C Cancrini, L Romiti, E Anastasio, A Plebani,
L Cursi, P Palma, G Castelli-Gattinara, P Rossi
(Italy)
ThPeA7156 Impaired maturation of CD8 T lymphocytes into
effector cells in HIV infected pediatric patients
V L Haridas, T W McCloskey, R Pahwa, S Pahwa
(United States)

ThPeA7157 TREC+ T cell levels are inversely related to HIV
replication and are selectively and rapidly
released into circulation with antiretroviral
treatment
M Diaz-lnsua', D Douek', H Valdez', B Hill',
D Peterson', I Sanne2, P Piliero', R Koup',
S Green', S Schnittman', M Lederman'
('United States; 2South Africa)
ThPeA7158 Impaired CD4+ cell counts recovery and immune
deactivation following highly active antiretroviral
therapy (HAART) among drug-naive HIV/HCVcoinfected patients
J A Pineda, J Macias, F Lozano, J E Corzo,
A Ramos, R Cozar, I A Garcia-Garcia,
F] JFernandez-Rivera, E Leon, J Gomez-Mateos
(Spain)
ThPeA7159 Effects of 6 months of highly active antiretroviral
therapy (HAART) on the CD8+ T-cell noncytotoxic
anti-HIV response (CNAR) in chronically
HIV-infected individuals at intermediate and late
stages of HIV disease
KJi Torres, F Gutierrez, A S Reyes, J Zuniga,
G Salgado, S Ridha, M E Mayar, M E Mackewicz,
G Reyes-Teran (Mexico)
ThPeA716o Changes in cytokine profile in HIV/AIDS patients
in the course of HAART
V Terzieva, R Markova, Y Todorova, H Taskov,
K Kostov (Bulgaria)
ThPeA7161 Long term immune reconstitution in HIV-1
infected subjects receiving potent antiretroviral
therapy
K Tsalimalma A Dimitrakopoulou, T Kordossis,
U Dafni, H Choremi-Papadopoulou (Greece)
ThPeA7162 CD8+ T cells that express CD4 on their surface
produce elevated levels of IL-4, are detected in
vivo, and can be infected by T-tropic HIV:
Relevance to HIV pathogenesis in the CD8+ T cell
compartment
Y B Sullivan, A Landay, L AI-Harthi (United States)
ThPeA7163 Evaluation of cervical immunity in HIV-1 and HPV
infected women
A F Nicol', A T G Fernandes', B G I Grinsztejn',
F Russomano', 0 Martinez-Maza2, J R Lapa e
Silva', M G Bonecini-Almeida'
('Brazil; 2United States)
ThPeA7164 Analysis of HIV- and CMV-specific memory CD4
T cell responses during primary and chronic
infections
A Harari, G P Rizzardi, K Ellefsen, D Ciuffreda,
M Khonkarly, L Kaiser, L Perrin, G Pantaleo
(Switzerland)
ThPeA7165 Colon eosinophilia in HIV-infected patients
A L Werneck-Silva I B Prado (Brazil)
ThPeA7166 HIV patients responding to HAART display
elevated IL-5 production
NM Keane P Price, S Lee, S F Stone, MA French
(Australia)
ThPeA7167 Increased diversity of TCRBV repertoire after 36
months of HAART
A Giovannetti, F Mazzetta, M Marziali,
M Pierdominici, D Santini Muratori, C Cascioli,
F Aiuti (Italy)
ThPeA7169 Interferon alpha production during primary HIV
infection correlates with impaired thymocyte
proliferation
M L Dion M Sylvestre, I F Poulin, R Bordi,
R Corsini, M Lainesse, R P Sekaly, R Cheynier

(Canada)

Final Program